José Antonio López García‐Asenjo

Randomized Phase 3 Trial of Fluorouracil, Epirubicin, and Cyclophosphamide Alone or Followed by Paclitaxel for Early Breast Cancer

Miguel Martín, Álvaro Rodríguez-Lescure, A. Ruiz et al. · JNCI Journal of the National Cancer Institute · 2008 · 239 citations · Full text

Medicine, Oncology, Pharmacology +15

Chemotherapy (CT) and hormonotherapy (HT) as neoadjuvant treatment in luminal breast cancer patients: results from the GEICAM/2006-03, a multicenter, randomized, phase-II study

Emilio Alba, Lourdes Calvo, Joan Albanell et al. · Annals of Oncology · 2012 · 226 citations · Full text

Medicine, Oncology, Breast Oncology +14

Adjuvant Docetaxel for High-Risk, Node-Negative Breast Cancer

Miguel Martín, Miguel Ángel Seguí, Antonio Antón et al. · New England Journal of Medicine · 2010 · 208 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

A randomized phase II trial of platinum salts in basal-like breast cancer patients in the neoadjuvant setting. Results from the GEICAM/2006-03, multicenter study

Emilio Alba, José Ignacio Chacón, Aňa Lluch et al. · Breast Cancer Research and Treatment · 2012 · 144 citations · Full text

Medicine, Oncology, Pharmacology +17

Genomic predictors of response to doxorubicin versus docetaxel in primary breast cancer

Miguel Martín, Atocha Romero, Maggie C.U. Cheang et al. · Breast Cancer Research and Treatment · 2011 · 72 citations · Full text

Medicine, Genetics, Oncology +16